IDEXX Laboratories, Inc. (ETR:IX1)

Market Cap	44.69B
Revenue (ttm)	3.44B
Net Income (ttm)	839.29M
Shares Out	n/a
EPS (ttm)	10.23
PE Ratio	53.25
Forward PE	49.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38
Average Volume	6
Open	555.20
Previous Close	543.20
Day's Range	555.20 - 555.20
52-Week Range	375.80 - 557.80
Beta	n/a
RSI	72.55
Earnings Date	Nov 3, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: IX1

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD